Accelerating Cell Line Development From Transfection to Manufacturing
Generating a highly expressing, regulatory compliant clonal cell line is key when developing a biopharmaceutical. Yet cell line development is labor-intensive, time consuming and costly.
The production of a high-quality and productive cell line requires both an expression system that yields high expressing clones and a workflow that allows selection of the highest producing clones.
In this webinar, you’ll discover how combining a single-cell analysis platform with a novel glutamine synthetase-Chinese hamster ovary expression system can yield highly productive, scalable, clonal cell lines for developing biopharmaceuticals.
Attend this webinar to:
- Hear about the workflow and techniques required to build a panel of scalable clones
- Learn about picodroplets and their advantages for cell line development
- Discover how real-world researchers drastically reduced their workflow timeline and costs
- Learn how automation can enable you to achieve regulatory accepted cells without compromising on monoclonality, traceability, productivity or scalability
Brought to you by
Now Available on Demand!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
